查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1867094

食道支架市場按產品類型、應用和最終用戶分類 - 全球預測 2025-2032

Esophageal Stents Market by Product Type, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，食道支架市場規模將達到 2.6342 億美元，複合年成長率為 6.47%。

關鍵市場統計數據
基準年 2024 1.5947億美元
預計年份：2025年 1.6992億美元
預測年份 2032 2.6342億美元
複合年成長率 (%) 6.47%

在器械設計、手術環境和利害關係人決策因素不斷創新的背景下，了解食道支架的臨床重要性和商業性背景

食道支架已成為阻塞性和穿孔性食道疾病多學科診療路徑中的治療方法，根據臨床情況，彌合了安寧療護、根治性治療和安寧療護之間的差距。材料科學、輸送系統和支架設計的最新創新拓展了臨床醫生的選擇範圍，並最佳化了手術流程。同時，醫保報銷模式的轉變和門診手術環境的不斷發展正在改變醫療服務的提供方式。隨著器械的不斷更新，從介入性胃腸病學家到醫院供應鏈管理人員等相關人員都面臨著臨床療效、手術效率和長期耐用性之間複雜的權衡取捨。

本導言對當前的醫療器材分類、常見臨床適應症以及影響採購和應用的宏觀經濟和監管趨勢進行了統一概述。這為深入探討醫療器材技術的變革性變化、新興貿易政策的影響、市場區隔主導的商業性意義、區域應用差異、製造商之間的競爭行為以及為領導者提供的實用建議奠定了基礎。貫穿始終的重點在於將技術進步轉化為營運和策略洞察，以支持實現最佳患者療效和永續的商業模式。

材料、輸送系統、監管重點和治療部位轉變等方面的進步正在重新定義食道支架的臨床實踐和商業模式。

食道支架領域正經歷著一場變革性的轉變，這主要得益於技術進步、臨床實踐的改變以及供應鏈的現代化。材料工程的進步加速了具有更佳徑向力控制和順應性的自膨脹金屬支架的普及應用。同時，生物可分解聚合物的進步為臨時支架的建造開闢了新的途徑，從而減少了取出支架的必要性。更小巧的輸送系統和更清晰的透視成像技術在許多情況下縮短了手術時間，使得更多手術能夠從住院手術室轉移到門診手術中心和專科診所。因此，臨床醫生能夠提供微創治療方案，並加快患者的康復速度，這正在改變轉診模式和醫保支付方的決策。

在醫療器材創新的同時，監管機構對上市後監測和真實世界數據的重視，也促使製造商更加關注長期臨床結果和器材註冊。醫療系統日益要求透過降低併發症率和再次手術率來體現可衡量的價值，這促使製造商投資於數據基礎設施和臨床合作。在商業方面，醫療服務提供者與支付方之間日益緊密的整合以及集中化的採購能力，正推動製造商開發全面的服務提案和靈活的合約模式。同時，支持術前規劃、術中指導和遠距追蹤的數位健康工具正逐漸成為兼具臨床效用和營運效率的差異化優勢，進一步加速了整合式醫療服務模式的轉變。

對美國對進口醫療設備組件和成品徵收關稅在營運、臨床准入和採購方面的影響進行全面評估

美國將於2025年實施的新關稅引發了一系列營運和戰略應對措施，這些措施對食道支架價值鏈產生了深遠影響，從原料採購到醫院採購委員會都受到了波及。關稅相關的成本壓力促使醫療設備製造商透過審查其採購基礎、探索替代材料以及尋求國內供應協議來降低風險。一些公司正在加快與首選合作夥伴的採購整合，以保持價格和前置作業時間的穩定性。另一些公司則在進行漸進式重新設計，以減少對關稅敏感型投入品的依賴。

臨床醫生和醫療系統採購團隊正面臨一系列後續影響，例如前置作業時間延長和供應商談判策略調整，這些都影響了庫存管理和手術安排。為了確保醫療資源的取得並按計劃開展手術，醫院正在採取多種策略，包括多供應商合約、策略性庫存緩衝以及與臨床團隊緊密合作，優先將設備分配給重症監護病例。同時，支付方和醫院財務負責人正在重新評估手術成本結構和報銷假設，更加關注可證實的臨床效益和總醫療成本。這些累積的調整凸顯了供應鏈、臨床領導和商業團隊需要通力合作，在應對不斷上漲的進口相關成本和日益嚴格的監管審查的同時，維持醫療服務的連續性。

細分市場對產品設計、臨床選擇標準和採購方式的影響源自於產品、應用和最終用戶的詳細差異。

市場區隔洞察表明，器材策略和商業化必須根據產品設計、臨床適應症和終端用戶環境量身定做，以最大限度地提高臨床適用性和商業性吸引力。從可生物分解平台到塑膠結構再到自膨脹金屬支架，各類產品各有其獨特的臨床優缺點。可生物分解支架非常適合臨時支撐場景，避免移位可帶來臨床效益。同時，聚乙烯和聚氨酯塑膠支架在一些特定細分市場中繼續發揮作用，這些市場優先考慮成本、易於部署和特定機械性能。自膨脹金屬塗層器械（包括鎳鈦合金和不銹鋼）在貼合性和徑向支撐力方面存在差異，這影響了它們在瘻管閉合和惡性狹窄安寧療護中的選擇。而當組織侵入性和長期通暢性是關鍵的臨床考量時，自膨脹非金屬塗層器械（同樣包括鎳鈦合金和不銹鋼）則非常有效。

以應用為導向的分類進一步明確了臨床路徑和商業性通訊。良性狹窄（細分為吻合口狹窄、消化道狹窄和放射相關狹窄）需要特別關注長期重塑以及臨時支架與永久支架的風險效益比。瘻管和穿孔病例需要快速閉合和高水平的即時徑向支撐，以防止污染並促進癒合。同時，惡性狹窄則優先考慮安寧療護、管腔通暢性和提高生活品質。終端使用者細分突顯了手術環境和採購複雜性的差異：門診手術中心優先考慮效率高、周轉率快的器械；私立和公立醫院力求平衡廣泛的治療組合和預算週期；專科診所則傾向於關注特定手術量和臨床醫生偏好模式。這些相互交織的細分觀點綜合起來表明，成功的產品策略應將材料科學和設計與特定的臨床適應症以及醫療機構的實際情況相結合。

美洲、歐洲、中東和非洲以及亞太地區的區域法規結構、支付方結構和供應鏈現狀將如何影響疫苗的採納和商業化策略

區域趨勢對食道支架的法規結構、報銷機制和臨床應用模式產生了顯著影響，要求製造商和服務提供者在不同地區採取差異化策略。在美洲，臨床上對微創介入治療的重視以及成熟的報銷體系，推動了先進自膨式金屬支架的應用，並將支架相關療效數據納入基本契約談判。同時，該地區的供應鏈中斷和關稅相關的複雜性促使製造商與大型醫院系統加強合作，以確保供應的連續性，並使合約條款與手術量相符。

不同的監管法規和醫療保健資金籌措模式正在以不同的方式影響歐洲、中東和非洲的醫療器材應用。在歐洲部分地區，完善的註冊登記和衛生技術評估流程推動了臨床證據和上市後追蹤標準的提高，這有利於那些能夠證明長期療效和成本效益的製造商。在中東和非洲的多個市場，基礎設施的限制和集中採購機制影響著醫療設備的組合和定價，這往往為耐用、低成本的解決方案以及包含臨床醫生培訓和支援的夥伴關係創造了機會。在亞太地區，醫院容量的快速擴張、手術量的增加以及對國內製造能力的投資正在加速金屬和可生物分解平台的應用，而當地的監管路徑和夥伴關係通常會影響市場進入的速度和方式。在所有地區，患者人口結構的變化和食道疾​​病發病率的上升支撐著持續的需求，但成功的市場策略需要與當地的臨床實踐模式、監管預期和採購生態系統進行細緻的調整。

透過材料創新、數據驅動的臨床支援以及影響合約授予和臨床醫生採納的策略性商業夥伴關係，實現競爭優勢。

公司層面的發展趨勢正受到產品創新、策略夥伴關係以及對供應鏈和監管要求的快速反應等因素的共同影響而重塑。領先的製造商正透過投資材料科學、最佳化鎳鈦諾和不銹鋼合金的製程以實現精確的徑向力分佈，以及推進用於臨時支架的可生物分解聚合物配方，從而實現差異化競爭。此外，一些公司正在拓展其價值提案，不再局限於單純的器械供應，而是提供培訓項目、數位化手術規劃工具和基於註冊登記的療效追蹤系統，以幫助推動臨床應用並與支付方進行價值對話。

競爭定位也體現在不同的市場進入模式。一些公司優先考慮與大型醫院系統和綜合醫療網路建立直接關係，而其他公司則利用分銷管道和區域合作夥伴關係來應對複雜的監管和採購環境。醫療器械製造商與診斷和影像技術提供者之間的策略聯盟也在不斷增加，這使他們能夠提供組合解決方案，從而提高植入精度並縮短手術時間。同時，中型企業和新參與企業通常在利基創新、特定監管轄區的上市速度以及為特定臨床領域客製化產品的靈活性方面展開競爭。製造地的選擇、供應商多元化以及對品質系統和上市後監管的承諾仍然是影響長期合約可靠性和永續性的決定性因素。

為製造商和醫療系統領導者提供切實可行的優先步驟，以加強證據產生、實現供應鏈多元化並使商業模式與臨床需求保持一致。

為維持成長並保障利潤率，產業領導者應採取多管齊下的方法，整合臨床證據產生、供應鏈韌性和靈活的商業性合約。首先，應優先進行強而有力的真實世界證據產生舉措和上市後註冊研究，以記錄醫療設備在關鍵適應症（例如吻合口狹窄、消化性潰瘍、放射性良性狹窄、惡性阻塞和瘻管治療）中的表現。這些數據資產將有助於加強與支付方的談判，並在以療效指標作為納入處方箋目錄先決條件的地區促進醫療器材的推廣應用。其次，應審查籌資策略，以減少對單一國家供應鏈的依賴，並制定緊急時應對計畫，包括合格的替代供應商、區域庫存地點以及允許在不影響臨床療效的前提下替換關稅敏感組件的設計方案。

第三，我們將提供一系列適用於門診手術中心、公立和私立醫院以及專科診所的設備和服務組合，並開發滿足終端用戶需求的商業模式。這些模式包括彈性價格設定、培訓和指導方案，以及在適當情況下採用績效付費的合約。第四，我們將投資臨床醫生教育和數位化工具，以提高手術效率和定位精度，從而改善臨床療效並向支付方證明其價值。最後，我們將積極與監管機構和衛生技術評估機構合作，協調證據生成計劃，並加快在重點地區的市場准入。這些措施的共同實施將使製造商和醫療系統能夠適應不斷變化的市場環境，滿足臨床醫生的期望，並提供永續的、以患者為中心的醫療服務。

我們採用透明的多來源調查方法，結合臨床醫生訪談、監管和臨床文獻審查以及三角供應鏈分析，以提供檢驗的策略見解。

本研究採用結構化的調查方法，融合了質性研究、系統性二手分析和嚴謹的三角驗證，以確保結論的可靠性和建議的可操作性。此方法首先進行有針對性的初步研究，包括對介入性胃腸病學家、醫院採購人員、臨床試驗研究人員和高級監管事務負責人進行深度訪談，以了解他們對醫療設備性能、臨床工作流程和關鍵採購問題的真實觀點。此外，還透過系統性回顧同行評審的臨床文獻、監管申報文件、醫療設備標籤和會議報告，補充了這些初步資訊，從而梳理出醫療設備類型、材料特性和治療結果方面的趨勢。

資料綜合涉及對多個資訊來源進行三角驗證，以消除差異並提取一致的主題，同時也要考慮監管要求和採購慣例的區域差異。細分框架已透過臨床醫生和機構層面的回饋檢驗了其實際應用價值。供應鏈分析納入了公開的貿易數據和檢驗的供應商資訊披露。限制在於，臨床實務存在差異，不斷變化的監管指南可能會改變商業環境，而製造商與大型客戶之間的合​​約條款並非總是完全透明。研究始終遵循倫理標準，所有結論均基於檢驗的證據和專家意見，以確保結論的可靠性和可操作性。

領導者必須整合臨床、營運和商業性方面的各項要素，才能在不斷發展的食道支架領域中保持永續的競爭優勢。

總之，食道支架領域正處於轉折點。材料創新、手術轉移到低風險醫療中心以及對實際療效日益成長的期望，正在重塑臨床實踐和商業策略。能夠根據特定臨床適應症客製化產品設計的製造商——無論是用於選擇性良性狹窄的臨時性可生物分解支架，還是用於惡性梗阻和瘻管的堅固金屬支架——都將更有利於滿足臨床醫生的需求和支付方的審查。同時，供應鏈的韌性和靈活的商業模式對於確保患者能夠獲得所需產品，同時應對不斷變化的貿易政策和採購壓力至關重要。

展望未來，策略重點在於實證實踐、臨床支援和本地市場適應，這將決定哪些機構能夠獲得永續的競爭優勢。那些在保持靈活的生產和籌資策略的同時，優先考慮醫療設備性能數據與醫療系統價值評估框架之間互通性的相關人員，將更有能力滿足不斷變化的臨床需求和監管要求。最終，在這個領域取得持續成功的關鍵在於制定一個整合研發、監管、供應鏈和商業團隊的綜合計劃，以交付能夠顯著改善患者預後和營運效率的醫療設備。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 可生物分解食道支架在治療良性食道狹窄的應用日益廣泛，並減少了支架取出手術。
  • 將先進的藥物釋放型塗層整合到食道支架上，以最大限度地減少腫瘤滲透並延長通暢性
  • 針對複雜解剖結構及個人化治療，開發患者特異性3D列印食道支架
  • 在惡性食道狹窄的安寧療護中，擴大使用全覆膜自膨式金屬支架
  • 推廣微創內視鏡支架留置技術，以縮短住院時間和降低併發症發生率
  • 為了防止食道支架形成生物膜和阻塞，抗菌奈米塗層的研究正在蓬勃發展。
  • 由於人口老化導致巴瑞特氏食道症和食道癌發生率上升，市場需求成長。

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 食道支架市場依產品類型分類

  • 可生物分解
  • 塑膠
    • 聚乙烯
    • 聚氨酯
  • 自膨式金屬塗層支架
    • 鎳鈦諾
    • 不銹鋼
  • 自膨脹金屬化
    • 鎳鈦諾
    • 不銹鋼

9. 食道支架市場依應用領域分類

  • 良性狹窄
    • 吻合口狹窄
    • 消化性狹窄
    • 放射學狹窄
  • 瘻管穿孔
  • 惡性狹窄

第10章 食道支架市場（依最終用戶分類）

  • 門診手術中心
  • 醫院
    • 私立醫院
    • 公立醫院
  • 專科診所

第11章 食道支架市場（按地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第12章 食道支架市場（依類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章 各國食道支架市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Boston Scientific Corporation
    • Cook Medical LLC
    • Medtronic plc
    • Taewoong Medical Co., Ltd.
    • Micro-Tech Endoscopy Co., Ltd.
    • Merit Medical Systems, Inc.
    • S&G Biotech, Inc.
    • Nanjing MicroPort Medical Company Limited
    • Guangzhou Wisco Medical Instrument Co., Ltd.
    • Well Lead Medical Co., Ltd.
Product Code: MRR-5D693B46C01D

The Esophageal Stents Market is projected to grow by USD 263.42 million at a CAGR of 6.47% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 159.47 million
Estimated Year [2025] USD 169.92 million
Forecast Year [2032] USD 263.42 million
CAGR (%) 6.47%

Framing the clinical importance and commercial context of esophageal stents amid innovations in device design, procedural settings, and stakeholder decision drivers

Esophageal stents have become a cornerstone intervention within multidisciplinary care pathways for obstructive and perforative esophageal disease, bridging palliation, definitive management, and temporizing measures depending on clinical context. Recent innovations in materials science, delivery systems, and stent design have expanded clinician choice and refined procedural workflows, while evolving reimbursement models and outpatient procedural settings have shifted how care is delivered. As devices evolve, stakeholders from interventional gastroenterologists to hospital supply chain leaders face complex trade-offs between clinical performance, procedural efficiency, and long-term durability.

This introduction synthesizes current device typologies, common clinical indications, and the macroeconomic and regulatory dynamics that shape procurement and adoption. It sets the stage for a deeper examination of transformative shifts in device technology, the ramifications of emergent trade policies, segmentation-driven commercial implications, regional variation in uptake, competitive behaviors among manufacturers, and pragmatic recommendations for leaders. Throughout, the emphasis is on translating technical developments into operational and strategic insights that support optimal patient outcomes and sustainable commercial models.

How converging advances in materials, delivery systems, regulatory focus, and care-site migration are redefining clinical practice and commercial models for esophageal stents

The landscape for esophageal stents is undergoing transformative shifts driven by technological refinement, clinical practice changes, and supply chain modernization. Advances in material engineering have accelerated the adoption of self-expanding metallic devices with improved radial force control and conformability, and simultaneous progress in biodegradable polymers is creating alternative pathways for temporary scaffolding that reduce the need for device retrieval. Delivery system miniaturization and enhanced fluoroscopic visibility have shortened procedural time in many cases, enabling more procedures to migrate from inpatient operating rooms to ambulatory surgical centers and specialty clinics. Consequently, clinicians can offer less invasive options with faster recovery, which reshapes referral patterns and payer conversations.

Alongside device innovation, regulatory emphasis on post-market surveillance and real-world evidence has heightened manufacturers' focus on longitudinal clinical outcomes and device registries. Health systems increasingly require demonstrable value through measurable reductions in complication rates and reintervention, prompting manufacturers to invest in data infrastructure and clinical partnerships. On the commercial front, consolidation among providers and payers is concentrating purchasing power, encouraging manufacturers to develop bundled-service propositions and flexible contracting models. Meanwhile, digital health tools that support pre-procedural planning, intra-procedural guidance, and remote follow-up are emerging as differentiators that align clinical utility with operational efficiencies, further accelerating the shift toward integrated care delivery models.

Assessment of the comprehensive operational, clinical access, and procurement consequences arising from United States tariff measures on imported medical device components and finished devices

The introduction of new tariff measures in the United States in 2025 has prompted a series of operational and strategic responses across the esophageal stent value chain, with effects felt from raw-material procurement to hospital purchasing committees. Tariff-related cost pressures have encouraged device manufacturers to reassess sourcing footprints and to explore alternative materials or domestic supply agreements to mitigate exposure. In some cases, companies have accelerated consolidation of component sourcing with preferred partners to preserve predictability in price and lead time, while others have pursued incremental redesigns that reduce reliance on tariff-sensitive inputs.

Clinicians and health system procurement teams have experienced downstream impacts through extended lead times and altered vendor negotiations, which in turn influence inventory management and procedural scheduling. To preserve access and keep procedures on schedule, hospitals have adopted a range of strategies including multi-vendor contracting, strategic inventory buffers, and closer collaboration with clinical teams to prioritize device allocation for high-acuity cases. Simultaneously, payers and hospital finance leaders are reassessing procedure cost structures and reimbursement assumptions, leading to renewed emphasis on demonstrable clinical benefit and total cost of care. These cumulative adjustments underscore the need for cross-functional coordination, with supply chain, clinical leadership, and commercial teams working together to maintain continuity of care while navigating elevated import-related costs and heightened regulatory scrutiny.

Segment-specific implications for product design, clinical selection criteria, and procurement approaches derived from detailed product, application, and end-user distinctions

Insight into segmentation reveals that device strategy and commercialization must be finely tailored to product design, clinical indication, and end-user environment to maximize clinical fit and commercial traction. Product type distinctions-ranging from biodegradable platforms to plastic constructs and self-expanding metallic options-carry unique clinical trade-offs. Biodegradable stents are positioned for temporary scaffolding scenarios where avoidance of removal confers clinical advantages, whereas plastic stents such as those constructed from polyethylene or polyurethane continue to serve defined niches where cost, ease of deployment, or specific mechanical properties are prioritized. Self-expanding metallic covered devices, available in nitinol and stainless steel variants, tend to offer differences in conformity and radial force that influence selection for sealing fistulae or palliation of malignant strictures, while self-expanding metallic uncovered versions, also in nitinol and stainless steel, remain relevant when tissue ingrowth and long-term patency considerations dominate clinical decision making.

Application-focused segmentation further clarifies clinical pathways and commercial messaging. Benign strictures-subdivided into anastomotic, peptic, and radiation-related etiologies-require particular attention to long-term remodeling and the risk-benefit profile of temporary versus permanent scaffolds. Fistula and perforation cases demand rapid sealing and high immediate radial support to prevent contamination and facilitate healing, while malignant strictures prioritize palliation, luminal patency, and quality-of-life outcomes. End-user segmentation highlights differences in procedural setting and procurement complexity: ambulatory surgical centers may prioritize devices optimized for efficiency and rapid turnover, hospitals-both private and public-must balance broad therapeutic portfolios and budget cycles, and specialty clinics often focus on niche procedural volumes and clinician preference patterns. Taken together, these intersecting segmentation lenses indicate that successful product strategies are those that align material science and design with specific clinical indications and the operational realities of the deploying institution.

How regional regulatory frameworks, payer structures, and supply chain realities across the Americas, Europe Middle East & Africa, and Asia-Pacific shape adoption and commercialization strategies

Regional dynamics exert a strong influence on regulatory frameworks, reimbursement practices, and clinical adoption patterns for esophageal stents, requiring manufacturers and service providers to adopt regionally differentiated strategies. In the Americas, the clinical emphasis on minimally invasive interventions and mature reimbursement systems has supported the adoption of advanced self-expanding metallic devices and the integration of device-related outcomes data into value-based contracting discussions. Conversely, supply chain disruptions and tariff-related complexities in the region have prompted closer collaboration between manufacturers and large hospital systems to ensure continuity of supply and to align contracting terms with procedural volumes.

Across Europe, the Middle East & Africa, regulatory heterogeneity and variable healthcare funding models shape adoption in distinct ways. In parts of Europe, strong registries and health technology assessment processes raise the bar for clinical evidence and post-market follow-up, favoring manufacturers that can demonstrate longitudinal outcomes and cost-effectiveness. In several Middle Eastern and African markets, infrastructural constraints and centralized procurement mechanisms influence device mix and pricing dynamics, often creating opportunities for durable, lower-cost solutions and for partnerships that include clinician training and support. In the Asia-Pacific region, rapid hospital capacity expansion, increasing procedural volumes, and investments in domestic manufacturing capacity are accelerating uptake of both metallic and biodegradable platforms, with local regulatory pathways and partnerships frequently shaping the speed and nature of market entry. Across all regions, evolving patient demographics and rising incidence of esophageal disease underscore persistent demand, but successful market strategies require nuanced alignment with regional clinical practice patterns, regulatory expectations, and procurement ecosystems.

Competitive differentiation through materials innovation, data-enabled clinical support, and strategic commercial partnerships that influence contract wins and clinician adoption

Company-level dynamics are being reshaped by a combination of product innovation, strategic partnerships, and operational responsiveness to supply chain and regulatory demands. Leading manufacturers are differentiating through investments in material science, optimizing nitinol and stainless steel alloy processes to achieve refined radial force profiles, and advancing biodegradable polymer formulations for temporary stenting applications. In addition, several firms are expanding their value propositions beyond pure device supply by offering training programs, digital procedural planning tools, and registry-based outcome tracking that enhance clinical adoption and support payer conversations on value.

Competitive positioning also reflects different go-to-market models: some companies emphasize direct relationships with large hospital systems and integrated health networks, while others leverage distributor channels and partnerships with local firms to navigate complex regulatory and procurement landscapes. Strategic collaborations between device manufacturers and diagnostic or imaging technology providers are becoming more common, enabling combined offerings that improve placement precision and reduce procedure time. At the same time, mid-sized firms and new entrants often compete on niche innovation, speed to market in specific regulatory jurisdictions, and agility in customizing products for distinct clinical segments. Manufacturing footprint decisions, supplier diversification, and commitment to quality systems and post-market surveillance remain decisive factors affecting credibility and long-term contract viability.

Practical and prioritized steps for manufacturers and health system leaders to strengthen evidence generation, diversify supply chains, and align commercial models with clinical site requirements

Industry leaders should adopt a multi-dimensional approach that integrates clinical evidence generation, supply chain resilience, and commercially flexible contracting to sustain growth and protect margins. First, prioritize robust real-world evidence initiatives and post-market registries that capture device performance across key indications such as anastomotic, peptic, and radiation-related benign strictures, as well as malignant obstruction and fistula management. These data assets will strengthen payer negotiations and facilitate adoption in settings where outcomes measurement is a prerequisite for formulary inclusion. Second, reassess sourcing strategies to reduce exposure to single-country supply chains, and develop contingency plans that include qualified alternative suppliers, localized inventory hubs, and design options that permit substitution of tariff-sensitive components without undermining clinical performance.

Third, tailor commercial models to end-user needs by offering device portfolios and service bundles suited to ambulatory surgical centers, private and public hospitals, and specialty clinics. This includes flexible pricing, training and proctoring packages, and outcome-based contracting where appropriate. Fourth, invest in clinician education and digital tools that enhance procedural efficiency and placement accuracy, thereby improving clinical outcomes and demonstrating value to payers. Finally, engage proactively with regulatory authorities and health technology assessment bodies to align evidence generation plans and to expedite market access in priority geographies. Taken together, these actions will enable manufacturers and health systems to navigate evolving trade environments, meet clinician expectations, and deliver sustainable patient-centered care.

A transparent multi-source methodology combining clinician interviews, regulatory and clinical literature review, and triangulated supply chain analysis to produce validated strategic insights

This research synthesizes a structured methodology that blends primary qualitative insights, systematic secondary analysis, and rigorous triangulation to ensure credible conclusions and actionable recommendations. The approach begins with targeted primary engagements including in-depth interviews with interventional gastroenterologists, hospital procurement leads, clinical trial investigators, and senior regulatory affairs professionals to capture frontline perspectives on device performance, clinical workflows, and procurement imperatives. These primary inputs are complemented by a systematic review of peer-reviewed clinical literature, regulatory filings, device labeling, and conference proceedings to map device typologies, material properties, and outcome trends.

Data synthesis employs triangulation across sources to reconcile differences and to surface consistent themes, with attention to geographic variability in regulatory requirements and procurement practices. Segmentation frameworks are validated against clinician- and institution-level feedback to ensure practical relevance, and supply chain analyses incorporate publicly available trade data and verified supplier disclosures. Limitations are acknowledged: clinical practice variation and evolving regulatory guidance can change the operational landscape, and proprietary contract terms between manufacturers and large customers are not always fully transparent. Throughout, ethical standards for research are observed, and claims are grounded in verified evidence and expert input to support defensible, actionable insights.

Synthesis of clinical, operational, and commercial imperatives that leaders must integrate to secure durable advantage in the evolving esophageal stent landscape

In conclusion, the esophageal stent sector is at an inflection point where material innovation, procedural migration to lower-acuity sites, and heightened expectations for real-world outcomes converge to reshape clinical practice and commercial strategy. Manufacturers that align product design with specific clinical indications-whether temporary biodegradable scaffolding for select benign strictures or robust metallic constructs for malignant obstruction and fistula-will be better positioned to satisfy clinician needs and payer scrutiny. Concurrently, supply chain resilience and adaptive commercial models are critical to navigate trade policy shifts and procurement pressures while preserving access to care.

Looking ahead, strategic emphasis on evidence generation, clinician support, and regional market tailoring will determine which organizations capture sustainable advantage. Stakeholders who prioritize interoperability between device performance data and health system value frameworks, while maintaining flexible manufacturing and sourcing strategies, will be best placed to respond to evolving clinical demands and regulatory expectations. Ultimately, the pathway to durable success in this sector requires integrated planning across R&D, regulatory affairs, supply chain, and commercial teams to deliver devices that demonstrably improve patient outcomes and operational efficiency.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of biodegradable esophageal stents for benign stricture management and reduced removal procedures
  • 5.2. Integration of advanced drug-eluting coatings on esophageal stents to minimize tumor ingrowth and prolong patency
  • 5.3. Development of patient-specific 3D-printed esophageal stents for complex anatomy and personalized therapy
  • 5.4. Increasing use of fully covered self-expanding metal stents in palliative care for malignant esophageal strictures
  • 5.5. Expansion of minimally invasive endoscopic stent placement techniques to shorten hospital stays and lower complication rates
  • 5.6. Surge in research on antimicrobial nanocoatings for esophageal stents to prevent biofilm formation and occlusion
  • 5.7. Market growth driven by rising incidence of Barrett's esophagus and esophageal cancer in aging populations

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Esophageal Stents Market, by Product Type

  • 8.1. Biodegradable
  • 8.2. Plastic
    • 8.2.1. Polyethylene
    • 8.2.2. Polyurethane
  • 8.3. Self Expanding Metallic Covered
    • 8.3.1. Nitinol
    • 8.3.2. Stainless Steel
  • 8.4. Self Expanding Metallic Uncovered
    • 8.4.1. Nitinol
    • 8.4.2. Stainless Steel

9. Esophageal Stents Market, by Application

  • 9.1. Benign Stricture
    • 9.1.1. Anastomotic Stricture
    • 9.1.2. Peptic Stricture
    • 9.1.3. Radiation Stricture
  • 9.2. Fistula Perforation
  • 9.3. Malignant Stricture

10. Esophageal Stents Market, by End User

  • 10.1. Ambulatory Surgical Center
  • 10.2. Hospital
    • 10.2.1. Private Hospital
    • 10.2.2. Public Hospital
  • 10.3. Specialty Clinic

11. Esophageal Stents Market, by Region

  • 11.1. Americas
    • 11.1.1. North America
    • 11.1.2. Latin America
  • 11.2. Europe, Middle East & Africa
    • 11.2.1. Europe
    • 11.2.2. Middle East
    • 11.2.3. Africa
  • 11.3. Asia-Pacific

12. Esophageal Stents Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Esophageal Stents Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Analysis
    • 14.3.1. Boston Scientific Corporation
    • 14.3.2. Cook Medical LLC
    • 14.3.3. Medtronic plc
    • 14.3.4. Taewoong Medical Co., Ltd.
    • 14.3.5. Micro-Tech Endoscopy Co., Ltd.
    • 14.3.6. Merit Medical Systems, Inc.
    • 14.3.7. S&G Biotech, Inc.
    • 14.3.8. Nanjing MicroPort Medical Company Limited
    • 14.3.9. Guangzhou Wisco Medical Instrument Co., Ltd.
    • 14.3.10. Well Lead Medical Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 9. AMERICAS ESOPHAGEAL STENTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. NORTH AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. LATIN AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. EUROPE, MIDDLE EAST & AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. EUROPE ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. MIDDLE EAST ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASEAN ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GCC ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. EUROPEAN UNION ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. BRICS ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. G7 ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. NATO ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. ESOPHAGEAL STENTS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 26. ESOPHAGEAL STENTS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ESOPHAGEAL STENTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY BIODEGRADABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY BIODEGRADABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY BIODEGRADABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY BIODEGRADABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY BIODEGRADABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY BIODEGRADABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY POLYETHYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY POLYETHYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY POLYETHYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY POLYETHYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY POLYETHYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY POLYETHYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY POLYURETHANE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY POLYURETHANE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY POLYURETHANE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY POLYURETHANE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY POLYURETHANE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY POLYURETHANE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY NITINOL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY NITINOL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY NITINOL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY NITINOL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY NITINOL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY NITINOL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY NITINOL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY NITINOL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY NITINOL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY NITINOL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY NITINOL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY NITINOL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY ANASTOMOTIC STRICTURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY ANASTOMOTIC STRICTURE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY ANASTOMOTIC STRICTURE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY ANASTOMOTIC STRICTURE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY ANASTOMOTIC STRICTURE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY ANASTOMOTIC STRICTURE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PEPTIC STRICTURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PEPTIC STRICTURE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PEPTIC STRICTURE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PEPTIC STRICTURE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PEPTIC STRICTURE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PEPTIC STRICTURE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY RADIATION STRICTURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY RADIATION STRICTURE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY RADIATION STRICTURE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY RADIATION STRICTURE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY RADIATION STRICTURE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY RADIATION STRICTURE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY FISTULA PERFORATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY FISTULA PERFORATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY FISTULA PERFORATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY FISTULA PERFORATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY FISTULA PERFORATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY FISTULA PERFORATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY MALIGNANT STRICTURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY MALIGNANT STRICTURE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY MALIGNANT STRICTURE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY MALIGNANT STRICTURE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY MALIGNANT STRICTURE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY MALIGNANT STRICTURE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PRIVATE HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PRIVATE HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PRIVATE HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PRIVATE HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PUBLIC HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PUBLIC HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PUBLIC HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PUBLIC HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SPECIALTY CLINIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SPECIALTY CLINIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SPECIALTY CLINIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SPECIALTY CLINIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. AMERICAS ESOPHAGEAL STENTS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 150. AMERICAS ESOPHAGEAL STENTS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 151. AMERICAS ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 152. AMERICAS ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 153. AMERICAS ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
  • TABLE 154. AMERICAS ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2025-2032 (USD MILLION)
  • TABLE 155. AMERICAS ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2018-2024 (USD MILLION)
  • TABLE 156. AMERICAS ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2025-2032 (USD MILLION)
  • TABLE 157. AMERICAS ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2018-2024 (USD MILLION)
  • TABLE 158. AMERICAS ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2025-2032 (USD MILLION)
  • TABLE 159. AMERICAS ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 160. AMERICAS ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 161. AMERICAS ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2018-2024 (USD MILLION)
  • TABLE 162. AMERICAS ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2025-2032 (USD MILLION)
  • TABLE 163. AMERICAS ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 164. AMERICAS ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 165. AMERICAS ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 166. AMERICAS ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. NORTH AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 170. NORTH AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
  • TABLE 172. NORTH AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2025-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2018-2024 (USD MILLION)
  • TABLE 174. NORTH AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2025-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2018-2024 (USD MILLION)
  • TABLE 176. NORTH AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2025-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 178. NORTH AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2018-2024 (USD MILLION)
  • TABLE 180. NORTH AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2025-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 182. NORTH AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 184. NORTH AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. LATIN AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 188. LATIN AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
  • TABLE 190. LATIN AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2025-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2018-2024 (USD MILLION)
  • TABLE 192. LATIN AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2025-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2018-2024 (USD MILLION)
  • TABLE 194. LATIN AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2025-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 196. LATIN AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2018-2024 (USD MILLION)
  • TABLE 198. LATIN AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2025-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 200. LATIN AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 202. LATIN AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2025-2032 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2025-2032 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPE ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 239. MIDDLE EAST ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. MIDDLE EAST ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. MIDDLE EAST ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 242. MIDDLE EAST ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 243. MIDDLE EAST ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
  • TABLE 244. MIDDLE EAST ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2025-2032 (USD MILLION)
  • TABLE 245. MIDDLE EAST ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2018-2024 (USD MILLION)
  • TABLE 246. MIDDLE EAST ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2025-2032 (USD MILLION)
  • TABLE 247. MIDDLE EAST ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2018-2024 (USD MILLION)
  • TABLE 248. MIDDLE EAST ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2025-2032 (USD MILLION)
  • TABLE 249. MIDDLE EAST ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 250. MIDDLE EAST ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 251. MIDDLE EAST ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2018-2024 (USD MILLION)
  • TABLE 252. MIDDLE EAST ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2025-2032 (USD MILLION)
  • TABLE 253. MIDDLE EAST ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 254. MIDDLE EAST ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 255. MIDDLE EAST ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 256. MIDDLE EAST ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 257. AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 260. AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 261. AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
  • TABLE 262. AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2025-2032 (USD MILLION)
  • TABLE 263. AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2018-2024 (USD MILLION)
  • TABLE 264. AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2025-2032 (USD MILLION)
  • TABLE 265. AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2018-2024 (USD MILLION)
  • TABLE 266. AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2025-2032 (USD MILLION)
  • TABLE 267. AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 268. AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 269. AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2018-2024 (USD MILLION)
  • TABLE 270. AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2025-2032 (USD MILLION)
  • TABLE 271. AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 272. AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 273. AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 274. AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 275. ASIA-PACIFIC ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 276. ASIA-PACIFIC ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 277. ASIA-PACIFIC ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 278. ASIA-PACIFIC ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 279. ASIA-PACIFIC ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
  • TABLE 280. ASIA-PACIFIC ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2025-2032 (USD MILLION)
  • TABLE 281. ASIA-PACIFIC ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2018-2024 (USD MILLION)
  • TABLE 282. ASIA-PACIFIC ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2025-2032 (USD MILLION)
  • TABLE 283. ASIA-PACIFIC ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2018-2024 (USD MILLION)
  • TABLE 284. ASIA-PACIFIC ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2025-2032 (USD MILLION)
  • TABLE 285. ASIA-PACIFIC ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 286. ASIA-PACIFIC ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 287. ASIA-PACIFIC ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2018-2024 (USD MILLION)
  • TABLE 288. ASIA-PACIFIC ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2025-2032 (USD MILLION)
  • TABLE 289. ASIA-PACIFIC ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 290. ASIA-PACIFIC ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 291. ASIA-PACIFIC ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 292. ASIA-PACIFIC ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 293. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 294. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 295. ASEAN ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 296. ASEAN ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 297. ASEAN ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 298. ASEAN ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 299. ASEAN ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
  • TABLE 300. ASEAN ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2025-2032 (USD MILLION)
  • TABLE 301. ASEAN ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2018-2024 (USD MILLION)
  • TABLE 302. ASEAN ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2025-2032 (USD MILLION)
  • TABLE 303. ASEAN ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2018-2024 (USD MILLION)
  • TABLE 304. ASEAN ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2025-2032 (USD MILLION)
  • TABLE 305. ASEAN ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 306. ASEAN ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 307. ASEAN ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2018-2024 (USD MILLION)
  • TABLE 308. ASEAN ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2025-2032 (USD MILLION)
  • TABLE 309. ASEAN ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 310. ASEAN ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 311. ASEAN ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 312. ASEAN ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 313. GCC ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 314. GCC ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 315. GCC ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 316. GCC ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 317. GCC ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2018-2024 (USD MILLION)
  • TABLE 318. GCC ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2025-2032 (USD MILLION)
  • TABLE 319. GCC ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2018-2024 (USD MILLION)
  • TABLE 320. GCC ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2025-2032 (USD MILLION)
  • TABLE 321. GCC ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2018-2024 (USD MILLION)
  • TABLE 322. GCC ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2025-2032 (USD MILLION)
  • TABLE 323. GCC ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 324. GCC ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 325. GCC ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2018-2024 (USD MILLION)
  • TABLE 326. GCC ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2025-2032 (USD MILLION)
  • TABLE 327. GCC ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 328. GCC ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 329. GCC ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 330. GCC ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2025-2032